Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
暂无分享,去创建一个
W. Klapper | E. Hoster | L. Sehn | K. Savage | L. Rimsza | M. Dreyling | O. Hermine | M. Unterhalt | C. Freeman | D. Villa | A. Gerrie | A. Bosly | M. Szymczyk | D. Scott | C. Ramsower